CoChat

Life expectancy following surgery for pituitary tumours

Bates, A. S., Bullivant, B., Sheppard, M. C., Stewart, P. M. · 1999 · Clinical Endocrinology
Cited by 108

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Hypopituitarism, predominantly al‐though not exclusively due to nonfunctioning pituitary tumours, has been associated with reduced life expectancy. Mortality from vascular diseases contributed significantly to the overall increase in mortality in some, but not all of the studies published to date. The aim of this study was to contribute further data to the debate regarding the putative association of vascular mortality with hypopituitarism. DESIGN AND PATIENTS: A retrospective case note review of patients undergoing pituitary surgery in Birmingham, between 1/1/70 and 1/1/92. Subjects were identified from neurosurgical and neuropathology records. 348 patients were identified of which 197 were male (median age at surgery 48.4, range 11–79 years) and 151 female (median age at surgery 47.8, range 9–78 years). All cause mortality and mortality from vascular disease was compared to the general population of the UK using the Person Years computer programme. RESULTS: There was a small increase in all cause mortality (SMR 1.2; 95% CI 0.95–1.55), but this was not statistically significant in this study (P = 0.06). Mortality from vascular disease was reduced (SMR 0.7; 95% CI 0.5–1.1; P = 0.03) particularly in the female cohort (SMR 0.5; 95% CI 0.2–1.0; P < 0.01) with the male subjects having similar mortality to that expected in an age and sex matched control population (SMR 0.9; 95% CI 0.5–1.4; P = 0.26). CONCLUSION: Although patients with pituitary deficiency may be subject to a small increase in all cause mortality, the results of this study do not support the view that hypopituitarism is associated with a significant increase in vascular disease. There is a pressing need for a large prospective study with comprehensive data collection, including both endocrine data and information regarding clinical outcome, to clarify this issue. In the interim it would seem prudent to base the need for GH replacement therapy on quality of life issues rather than any potential for increased longevity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2265.1999.00650.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 108

Metadata

Authors
Bates, A. S., Bullivant, B., Sheppard, M. C., & Stewart, P. M.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
1999-03
Volume
50
Issue
3
Pages
315-319
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W1897422538
Cited by
108
References
6
FWCI
5.96
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Life expectancy following surgery for pituitary tumours. https://app.cochat.ai/papers/10.1046/j.1365-2265.1999.00650.x
The paper
Bates, A. S., Bullivant, B., Sheppard, M. C., & Stewart, P. M. (1999). Life expectancy following surgery for pituitary tumours. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.1999.00650.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.